Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Cascades Inc T.CAS

Alternate Symbol(s):  CADNF

Cascades Inc. is a Canada-based paper and packaging company. The Company specializes in producing, converting, and marketing packaging and tissue products composed primarily of recycled fibers. The Company's operations are managed in three segments: Containerboard and Specialty Products (which constitute the Corporations Packaging Products) and Tissue Papers. The Containerboard segment is a manufacturer of containerboard and converter of corrugated products in North America. The Specialty Products Group manufactures industrial and food packaging products. The Tissue Papers segment manufactures tissue paper reels and converts them into finished products for the professional and residential markets. The Company also provides recycling solutions. The Company has approximately 80 operating facilities across Canada and the United States.


TSX:CAS - Post by User

<< Previous
Bullboard Posts
Next >>
Post by Possibleidiot01on Feb 25, 2022 3:24pm
278 Views
Post# 34462791

analyst actions

analyst actions
  • Cascades (TSE:CAS) had its price target lowered by analysts at Royal Bank of Canada from C$20.00 to C$17.00. They now have an "outperform" rating on the stock.This represents a 31.8% upside from the current price of C$12.90. Read More.
  • Cascades (TSE:CAS) had its price target lowered by analysts at TD Securities from C$15.50 to C$14.00. They now have a "hold" rating on the stock.This represents a 8.5% upside from the current price of C$12.90.
Tissue group seems to be a problem spot for the company
<< Previous
Bullboard Posts
Next >>